Precigen logo
Precigen PGEN
€ 3.11 -3.83%

Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025

report update icon

Precigen DSO 2011-2026 | PGEN

DSO Jährlich Precigen

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 212 106 63.8 63 81.2 110 148 113 - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
212 63 112

DSO Vierteljährlich Precigen

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - 80.7 67.8 - 6.77 401 212 - 632 560 69.4 77.8 63.8 49.5 56.8 111 103 57.4 84.5 46.9 64.3 45.2 50.3 23.4 39.2 33.1 35.1 42.9 40.3 37.6 49.1 55.2 42.9 51 53.5 42.8 62.8 113 89.3 10.1 11.9 10.8 10.9 1.96 4.4 2.36 - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
632 1.96 86.1

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
78.4 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Codexis Codexis
CDXS
32.9 $ 1.02 1.49 % $ 74.9 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 3.74 3.6 % $ 1.12 B canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Cerus Corporation Cerus Corporation
CERS
59.2 $ 2.6 1.37 % $ 480 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Cellectis S.A. Cellectis S.A.
CLLS
94.5 $ 3.87 -0.39 % $ 116 M franceFrance
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
391 $ 41.75 0.19 % $ 1.32 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
27.3 $ 36.14 1.23 % $ 3.75 B usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
157 $ 13.98 1.27 % $ 5.7 B irlandaIrlanda
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
59.5 $ 23.77 2.99 % $ 2.91 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
239 $ 8.41 -1.87 % $ 36.4 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
294 $ 1.94 0.01 % $ 130 M usaUSA
Curis Curis
CRIS
103 $ 1.1 -3.51 % $ 6.94 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
CorMedix CorMedix
CRMD
127 $ 7.16 0.42 % $ 364 M usaUSA
Champions Oncology Champions Oncology
CSBR
66.5 $ 6.14 3.89 % $ 83.9 M usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
59 - 17.91 % $ 11.1 M usaUSA
Altimmune Altimmune
ALT
15.1 K $ 4.21 -2.32 % $ 299 M usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
227 $ 3.88 -8.92 % $ 247 M usaUSA